UNLABELLED: Intravenous (IV) arginine invokes an increase in growth hormone (GH) concentrations, however, little is known about the impact of oral arginine ingestion on the GH response. OBJECTIVE: The purpose of this study was to determine the dose of oral arginine that elicits an optimal GH response and to determine the time course of the response. DESIGN:Eight healthy males (18-33 years - 24.8+/-1.2 years) were studied on 4 separate occasions. Following an overnight fast at 0700 h, a catheter was placed in a forearm vein. Blood samples were taken every 10 min for 5 h. Thirty minutes after sampling was initiated, the subject ingested a dose of arginine (5, 9 or 13 g) or placebo (randomly assigned). RESULTS:Mean resting GH values for the placebo, 5, 9 and 13 g day were 0.76, 0.67, 2.0 and 0.79 microg/L (n=6), respectively. Integrated area under the curve was not different with 13 g (197.8+/-65.7 min microg/L), yet it increased with 5 and 9 g compared with the placebo (301.5+/-74.6, 524.28+/-82.9 and 186.04+/-47.8 min microg/L, respectively, P<0.05). Mean peak GH levels were 2.9+/-0.69, 3.9+/-0.85, 6.4+/-1.3 and 4.73+/-1.27 microg/L on each day for the placebo, 5, 9 and 13 g days. CONCLUSION: In conclusion, 5 and 9 g of oral arginine caused a significant GH response. A 13 g dose of arginine resulted in considerable gastrointestinal distress in most subjects without augmentation in the GH response. The rise in GH concentration started approximately 30 min after ingestion and peaked approximately 60 min post ingestion.
RCT Entities:
UNLABELLED: Intravenous (IV) arginine invokes an increase in growth hormone (GH) concentrations, however, little is known about the impact of oral arginine ingestion on the GH response. OBJECTIVE: The purpose of this study was to determine the dose of oral arginine that elicits an optimal GH response and to determine the time course of the response. DESIGN: Eight healthy males (18-33 years - 24.8+/-1.2 years) were studied on 4 separate occasions. Following an overnight fast at 0700 h, a catheter was placed in a forearm vein. Blood samples were taken every 10 min for 5 h. Thirty minutes after sampling was initiated, the subject ingested a dose of arginine (5, 9 or 13 g) or placebo (randomly assigned). RESULTS: Mean resting GH values for the placebo, 5, 9 and 13 g day were 0.76, 0.67, 2.0 and 0.79 microg/L (n=6), respectively. Integrated area under the curve was not different with 13 g (197.8+/-65.7 min microg/L), yet it increased with 5 and 9 g compared with the placebo (301.5+/-74.6, 524.28+/-82.9 and 186.04+/-47.8 min microg/L, respectively, P<0.05). Mean peak GH levels were 2.9+/-0.69, 3.9+/-0.85, 6.4+/-1.3 and 4.73+/-1.27 microg/L on each day for the placebo, 5, 9 and 13 g days. CONCLUSION: In conclusion, 5 and 9 g of oral arginine caused a significant GH response. A 13 g dose of arginine resulted in considerable gastrointestinal distress in most subjects without augmentation in the GH response. The rise in GH concentration started approximately 30 min after ingestion and peaked approximately 60 min post ingestion.
Authors: Kevin S Heffernan; Christopher A Fahs; Sushant M Ranadive; Eshan A Patvardhan Journal: J Cardiovasc Pharmacol Ther Date: 2010-01-06 Impact factor: 2.457
Authors: Stacy R Oliver; Jaime S Rosa; Timothy D C Minh; Andria M Pontello; Rebecca L Flores; Marcia Barnett; Pietro R Galassetti Journal: J Appl Physiol (1985) Date: 2009-10-29
Authors: Davi Vieira Teixeira da Silva; Carlos Adam Conte-Junior; Vânia Margaret Flosi Paschoalin; Thiago da Silveira Alvares Journal: Food Nutr Res Date: 2014-03-25 Impact factor: 3.894
Authors: Jeremy R Townsend; Jay R Hoffman; Adam M Gonzalez; Adam R Jajtner; Carleigh H Boone; Edward H Robinson; Gerald T Mangine; Adam J Wells; Maren S Fragala; David H Fukuda; Jeffrey R Stout Journal: Int J Endocrinol Date: 2015-02-22 Impact factor: 3.257
Authors: Susanne M Steggerda; Mark K Bennett; Jason Chen; Ethan Emberley; Tony Huang; Julie R Janes; Weiqun Li; Andrew L MacKinnon; Amani Makkouk; Gisele Marguier; Peter J Murray; Silinda Neou; Alison Pan; Francesco Parlati; Mirna L M Rodriguez; Lee-Ann Van de Velde; Tracy Wang; Melissa Works; Jing Zhang; Winter Zhang; Matthew I Gross Journal: J Immunother Cancer Date: 2017-12-19 Impact factor: 13.751